Mutual of America Capital Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,746
| Closed | -$753K | – | 1638 |
|
|
2022
Q1 | $753K | Sell |
22,746
-987
| -4% | -$32.7K | 0.01% | 1068 |
|
|
2021
Q4 | $1.01M | Sell |
23,733
-221
| -0.9% | -$9.41K | 0.01% | 1059 |
|
|
2021
Q3 | $1.06M | Sell |
23,954
-2,101
| -8% | -$93.1K | 0.01% | 1067 |
|
|
2021
Q2 | $1.48M | Sell |
26,055
-1,180
| -4% | -$67K | 0.01% | 1045 |
|
|
2021
Q1 | $2.04M | Sell |
27,235
-1,456
| -5% | -$109K | 0.02% | 958 |
|
|
2020
Q4 | $2.48M | Sell |
28,691
-665
| -2% | -$57.5K | 0.03% | 814 |
|
|
2020
Q3 | $1.79M | Sell |
29,356
-4,680
| -14% | -$286K | 0.02% | 872 |
|
|
2020
Q2 | $1.42M | Buy |
34,036
+10,420
| +44% | +$433K | 0.02% | 960 |
|
|
2020
Q1 | $678K | Buy |
23,616
+39
| +0.2% | +$1.12K | 0.01% | 1052 |
|
|
2019
Q4 | $1.7M | Buy |
23,577
+10,254
| +77% | +$740K | 0.02% | 975 |
|
|
2019
Q3 | $1.87M | Sell |
13,323
-2,810
| -17% | -$394K | 0.03% | 890 |
|
|
2019
Q2 | $2.95M | Buy |
16,133
+10
| +0.1% | +$1.83K | 0.04% | 691 |
|
|
2019
Q1 | $2.56M | Buy |
16,123
+287
| +2% | +$45.6K | 0.04% | 751 |
|
|
2018
Q4 | $1.52M | Hold |
15,836
| – | – | 0.03% | 926 |
|
|
2018
Q3 | $2.24M | Sell |
15,836
-9,214
| -37% | -$1.3M | 0.03% | 850 |
|
|
2018
Q2 | $3.92M | Sell |
25,050
-10,165
| -29% | -$1.59M | 0.06% | 528 |
|
|
2018
Q1 | $5.67M | Sell |
35,215
-150
| -0.4% | -$24.2K | 0.09% | 310 |
|
|
2017
Q4 | $5.83M | Sell |
35,365
-1,981
| -5% | -$326K | 0.09% | 316 |
|
|
2017
Q3 | $2.33M | Buy |
37,346
+8,600
| +30% | +$536K | 0.04% | 777 |
|
|
2017
Q2 | $2.29M | Buy |
28,746
+27,696
| +2,638% | +$2.21M | 0.04% | 763 |
|
|
2017
Q1 | $75K | Buy |
+1,050
| New | +$75K | ﹤0.01% | 1168 |
|